Cosentyx and Slow response to stimuli - a phase IV clinical study of FDA data

Summary:

Slow response to stimuli is reported only by a few people who take Cosentyx.

The phase IV clinical study analyzes which people take Cosentyx and have Slow response to stimuli. It is created by eHealthMe based on reports of 141,444 people who have side effects while taking Cosentyx from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 24, 2022

141,444 people reported to have side effects when taking Cosentyx.
Among them, 2 people (0.0%) have Slow response to stimuli.


What is Cosentyx?

Cosentyx has active ingredients of secukinumab. It is often used in psoriatic arthritis. eHealthMe is studying from 141,622 Cosentyx users for its effectiveness, alternative drugs and more.

What is Slow response to stimuli?

Slow response to stimuli (slow response by nerves) is found to be associated with 530 drugs and 308 conditions by eHealthMe.

Number of Cosentyx and Slow response to stimuli reports submitted per year:

Could Cosentyx cause Slow response to stimuli?

Gender of people who have Slow response to stimuli when taking Cosentyx *:

  • female: 50 %
  • male: 50 %

Age of people who have Slow response to stimuli when taking Cosentyx *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common side effects people have besides Slow response to stimuli *:

  1. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 1 person, 50.00%
  2. Malaise (a feeling of general discomfort or uneasiness): 1 person, 50.00%
  3. Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 1 person, 50.00%
  4. Confusional State: 1 person, 50.00%
  5. Chest Pain: 1 person, 50.00%

Common conditions people have *:

  1. Psoriasis (immune-mediated disease that affects the skin): 1 person, 50.00%
  2. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cosentyx and have Slow response to stimuli?

Check whether Slow response to stimuli is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Slow response to stimuli and when was it recovered:

Expand to all the drugs that have ingredients of secukinumab:

Alternative drugs to, pros and cons of Cosentyx:

Common Cosentyx side effects:

Browse all side effects of Cosentyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Slow response to stimuli treatments and more:

COVID vaccines that are related to Slow response to stimuli:

All the drugs that are associated with Slow response to stimuli:

All the conditions that are associated with Slow response to stimuli:

How the study uses the data?

The study uses data from the FDA. It is based on secukinumab (the active ingredients of Cosentyx) and Cosentyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: